Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dilaudid CR vs OxyContin in Chronic Osteoarthritis
NCT00399048Phase 3Completed
- Sponsor
- ALZA Corporation
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of hydromorphone in osteoarthritis (OA), sponsored by ALZA Corporation. Status: completed.
02
Drugs
hydromorphone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00399048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399048.